Hayley Emma Arron: Supporting Future Strategies for Venous Thrombosis in Spaceflight and Exploration
Hayley Emma Arron, Research Fellow at the European Space Agency, shared a post on LinkedIn:
“Venous Thrombosis RFI – March 2026
ESA and NASA have released a Request for Information (RFI) to support planning and future acquisition strategies related to venous thrombosis (VT) in spaceflight and exploration missions.
The agencies are seeking input on approaches to:
- Monitor VT
- Reduce associated risks
- Develop potential treatment strategies
Contributions may also include recommendations for future spaceflight and analogue research relevant to VT.
All information provided will be used on a non-attribution basis to inform ongoing planning efforts.
Submission deadline: 15 April 2026 (23:59 CET)
If your work aligns with these areas, this is an opportunity to help inform the future direction of human spaceflight health initiatives.”
Angelique Van Ombergen, Chief Exploration Scientist at European Space Agency, shared this post, adding:
“Joint ESA/NASA Request for Information (RFI) on venous thrombosis in space open now!
Submit your ideas by the deadline of 15th of April 2026 via the link below.”
Stay updated with Hemostasis Today.
-
Apr 1, 2026, 14:58Steve Cleveland: Tumor-Educated Platelets as a Platform for Early Cancer Detection
-
Apr 1, 2026, 14:44Chad Mineo: Platelet-Rich Plasma as an Adjunct to Rehabilitation in Grade 2 Hamstring Injuries
-
Apr 1, 2026, 14:41How Psychosocial Care Transforms Fear into Clarity and Stability – WFH
-
Apr 1, 2026, 14:23Ingo Ahrens: When Bleeding Poses a Greater Risk Than Ischemia
-
Apr 1, 2026, 13:48Anas Ibraheem: Apixaban Shows Superior Safety in Acute VTE While Matching Rivaroxaban Efficacy
-
Apr 1, 2026, 13:29Kevin Shortall: Life-Saving Blood Donation Amid Ireland’s Shortage
-
Apr 1, 2026, 13:12Kalyan Roy: Wrong Blood in Tube – A Small Error with Life-Threatening Consequences
-
Apr 1, 2026, 12:37Yves Bikorimana։ Normal MCV Doesn’t Always Mean Normal RBCs
-
Apr 1, 2026, 12:09Maxime Dely: Helping Patients Live More Freely with Sickle Cell Disease